← SynDRA

LAZABEMIDE

SynDRA canonical compound SYN0001105 — structure-anchored drug synonym record

All known targets

• MAOB

Mechanisms of action (all sources)

• Monoamine oxidase inhibitor
• MAOB INHIBITOR

Drug classes

• Antiparkinson Agents
• Monoamine Oxidase Inhibitors

Cross-references

• PubChem CID: 71307
• ChEMBL: CHEMBL279390
• DrugBank: DB19878
• ChEBI: CHEBI:31766
• KEGG: D04681
• TTD: D06QRW
• LINCS BRD: BRD-K51486818

Synonyms

• Lazabemida
• RO-19-6327/000
• RO-196327
• Ro-19-6327
• N-(2-Aminoethyl)-5-chloropicolinamide
• CCRIS 7301
• UNII-420HD787N9
• N-(2-aminoethyl)-5-chloropyridine-2-carboxamide
• Ro 19-6327 hydrate
• CHEMBL279390
• Ro-19-6327/000
• 420HD787N9
• C8H10ClN3O
• 2-Pyridinecarboxamide, N-(2-aminoethyl)-5-chloro-
• N-(2-Aminoethyl)-5-chloro-2-pyridinecarboxamide hydrate
• N-(2-Aminoethyl)-5-chloro-2-pyridinecarboxamide;N-(2-Aminoethyl)-5-chloro-2-pyridinecarboxamide
• NCGC00167737-01
• Lazabemide [USAN:INN]
• Lazabemide [USAN:INN:BAN]
• Lazabemine
• Pakio
• Tempium
• Ro-41-3776
• LAZEBEMIDE
• Ro-196327
• lazabemidum
• RefChem:924579
• DTXCID3028269
• Ro 19-6327
• JZXRLKWWVNUZRB-UHFFFAOYSA-N
• LAZABEMIDE [MI]
• LAZABEMIDE [INN]
• Lazabemide (USAN/INN)
• LAZABEMIDE [USAN]
• LAZABEMIDE [MART.]
• LAZABEMIDE [WHO-DD]
• SCHEMBL121998
• GTPL6640